Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life and Surgical Late Effects of Melanoma Treatment

NCT02352623 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02352623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life and Surgical Late Effects of Melanoma Treatment
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
May 31, 2016
Enrollment
435 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cicatrix, depression, lymphedema, melanoma, pain, quality of life